Compare JAZZ & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | NWS |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 17.9B |
| IPO Year | 2007 | 2012 |
| Metric | JAZZ | NWS |
|---|---|---|
| Price | $208.12 | $32.95 |
| Analyst Decision | Buy | |
| Analyst Count | 22 | 0 |
| Target Price | ★ $294.64 | N/A |
| AVG Volume (30 Days) | 715.2K | ★ 839.4K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.17 | 1.03 |
| Revenue | $1,618,693,000.00 | ★ $9,028,000,000.00 |
| Revenue This Year | $10.65 | $4.24 |
| Revenue Next Year | $5.76 | $3.48 |
| P/E Ratio | ★ $29.35 | $31.94 |
| Revenue Growth | N/A | ★ 6.81 |
| 52 Week Low | $128.80 | $25.49 |
| 52 Week High | $266.38 | $35.76 |
| Indicator | JAZZ | NWS |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 53.28 |
| Support Level | $194.77 | $32.49 |
| Resistance Level | $241.39 | $32.91 |
| Average True Range (ATR) | 6.94 | 0.54 |
| MACD | -1.78 | 0.17 |
| Stochastic Oscillator | 4.51 | 68.88 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
News Corporation is a diversified media and information services conglomerate with significant presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.